QAB BLOOD
Dead / Cancelled — Cancelled — Section 8 (as of 28 Jan 2011)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 75266063
- Registration number
- 2362582
- Mark type
- Word mark
- Filed
- 28 Mar 1997
- Published for opposition
- 31 Mar 1998
- Registered
- 27 Jun 2000
- Attorney of record
- Laura E. Goldbard
Goods and services
- Class 005 — Pharmaceuticals: blood products, namely, blood plasma, red blood cells, blood platelets and cryoprecipitate
Owner
- Daxor Corporation, New York, NY, US
- Daxor Corporation, New York, NY, US
- Daxor Corporation, New York, NY, US
Prosecution history
- 28 Jan 2011 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 22 Mar 2006 — CASE FILE IN TICRS
- 06 Mar 2006 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 06 Mar 2006 — ASSIGNED TO PARALEGAL
- 06 Dec 2005 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 06 Dec 2005 — TEAS SECTION 8 & 15 RECEIVED
- 27 Jun 2000 — REGISTERED-PRINCIPAL REGISTER
- 25 Apr 2000 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Dec 1999 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Oct 1999 — NON-FINAL ACTION MAILED
- 12 Aug 1999 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Jan 2000 — SOU EXTENSION 3 GRANTED
- 24 Nov 1999 — SOU EXTENSION 3 FILED
- 06 Jul 1999 — USE AMENDMENT FILED
- 07 Jul 1999 — SOU EXTENSION 2 GRANTED